1. Feasibility of establishing PVC in the Ugandan health system By Juliet & Martin September 2004

2. Why monitor drugs To document unknown Adverse Drug Reactions (ADR) and maximize safety To encourage health professionals to share concerns about drugs – create an awareness of safety issues & drugs

3. What should be monitored? All drugs, but priority to be given to ARVs, anti malarials, TB drugs.

4. Which reports to be investigated? All suspected ADR but with special emphasis on unexpected ADRs and those that significantly affect compliance

5. Who monitors? Health workers and care givers The PV teams and MTC

6. How should monitoring occur? patients NPVC HW RPVC monitoring Monitoring monitoring Regular reports Less regular

7. When to encourage reporting events or reactions 2 weeks to one month

8. How to manage non serious events Sensitization of patients and health workers on frequent occurrences that may affect compliance

9. Resources available HR can be mobilized Financial resources are limited and needs mobilizing

10. Critical success factors Adequate financial resources Good communication A good infrastructure (labs, equipment etc) Well trained and sensitized health workers Good will by all parties